Unlike most other older medications for the treatment of type 2 diabetes mellitus, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) promote weight loss addressing the common type 2 diabetes comorbidity, obesity. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.